TW200303724A - Pet food composition for skin photoprotection - Google Patents
Pet food composition for skin photoprotection Download PDFInfo
- Publication number
- TW200303724A TW200303724A TW092103672A TW92103672A TW200303724A TW 200303724 A TW200303724 A TW 200303724A TW 092103672 A TW092103672 A TW 092103672A TW 92103672 A TW92103672 A TW 92103672A TW 200303724 A TW200303724 A TW 200303724A
- Authority
- TW
- Taiwan
- Prior art keywords
- bifidobacterium
- lactic acid
- lactobacillus
- composition
- scope
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 230000003711 photoprotective effect Effects 0.000 title claims abstract description 12
- 235000013305 food Nutrition 0.000 title claims description 27
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 29
- 239000006041 probiotic Substances 0.000 claims abstract description 22
- 235000018291 probiotics Nutrition 0.000 claims abstract description 22
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 18
- 239000004310 lactic acid Substances 0.000 claims abstract description 18
- 230000000529 probiotic effect Effects 0.000 claims abstract description 18
- 241000894006 Bacteria Species 0.000 claims abstract description 17
- 235000021466 carotenoid Nutrition 0.000 claims abstract description 16
- 150000001747 carotenoids Chemical class 0.000 claims abstract description 16
- 239000012228 culture supernatant Substances 0.000 claims abstract description 9
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 16
- 230000005855 radiation Effects 0.000 claims description 16
- 230000004224 protection Effects 0.000 claims description 9
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 7
- 241000186000 Bifidobacterium Species 0.000 claims description 6
- 229940039696 lactobacillus Drugs 0.000 claims description 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 5
- 235000013734 beta-carotene Nutrition 0.000 claims description 5
- 239000011648 beta-carotene Substances 0.000 claims description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 5
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 4
- 241001608472 Bifidobacterium longum Species 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 241000235070 Saccharomyces Species 0.000 claims description 4
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 4
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 4
- 239000001656 lutein Substances 0.000 claims description 4
- 235000012680 lutein Nutrition 0.000 claims description 4
- 229960005375 lutein Drugs 0.000 claims description 4
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 4
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000013589 supplement Substances 0.000 claims description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 4
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 4
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 3
- 241000186012 Bifidobacterium breve Species 0.000 claims description 3
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 3
- 241000235035 Debaryomyces Species 0.000 claims description 3
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 3
- 241000235013 Yarrowia Species 0.000 claims description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 3
- 229960002747 betacarotene Drugs 0.000 claims description 3
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 3
- 150000001746 carotenes Chemical class 0.000 claims description 3
- 235000005473 carotenes Nutrition 0.000 claims description 3
- 239000008176 lyophilized powder Substances 0.000 claims description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 3
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 claims description 2
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 2
- 241001134772 Bifidobacterium pseudocatenulatum Species 0.000 claims description 2
- 241000194033 Enterococcus Species 0.000 claims description 2
- 241000194031 Enterococcus faecium Species 0.000 claims description 2
- 241000235649 Kluyveromyces Species 0.000 claims description 2
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 2
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- 241000235017 Zygosaccharomyces Species 0.000 claims description 2
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 2
- 235000015872 dietary supplement Nutrition 0.000 claims description 2
- 230000037406 food intake Effects 0.000 claims description 2
- 239000011663 gamma-carotene Substances 0.000 claims description 2
- 235000000633 gamma-carotene Nutrition 0.000 claims description 2
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 claims description 2
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 claims 3
- 229940017800 lactobacillus casei Drugs 0.000 claims 3
- 240000000073 Achillea millefolium Species 0.000 claims 1
- 235000007754 Achillea millefolium Nutrition 0.000 claims 1
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 241000194032 Enterococcus faecalis Species 0.000 claims 1
- 241001495410 Enterococcus sp. Species 0.000 claims 1
- 241000192041 Micrococcus Species 0.000 claims 1
- 206010051246 Photodermatosis Diseases 0.000 claims 1
- 235000008429 bread Nutrition 0.000 claims 1
- 238000010586 diagram Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940032049 enterococcus faecalis Drugs 0.000 claims 1
- 229940068140 lactobacillus bifidus Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000008845 photoaging Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 23
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 18
- 239000000047 product Substances 0.000 description 8
- 244000005700 microbiome Species 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 235000013406 prebiotics Nutrition 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 244000298479 Cichorium intybus Species 0.000 description 3
- 235000007542 Cichorium intybus Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000021336 beef liver Nutrition 0.000 description 1
- 239000010473 blackcurrant seed oil Substances 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- ZGVSETXHNHBTRK-UDJLNJFBSA-N solanine Chemical compound O([C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5N6C[C@@H](C)CC[C@@H]6[C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZGVSETXHNHBTRK-UDJLNJFBSA-N 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000005028 tinplate Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/535—Pseudocatenulatum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Description
200303724
玖、發明說明 ^ (發明說明應敘明:發明所屬之技術領域、先前技術、内容、貫施方式及圖式簡單說明) 技術領域 本發明係關於寵物食物組合物,其用於皮膚之光保護, 無論於暴露至UV輻射之前、之間及/或之後,並關於其應用 以預防及/或減輕此等UV輻射所造成之傷害。亦關於一種改 善皮膚之光保護之方法。 先前技術 大氣臭-氧層之持續減少同時使得 射之增加,其對人體健康之潛在影響已引起極大之關注 實際上,咸知波長自320奈米至400奈米之光輻射(UV_A) 可促進人類表皮之曬黑;然@,此等輻射可能會造成皮膚 損害,㈣是對於敏感皮膚或是連續暴露於太陽輕射之: 膚。特定言之,UV-A光會造成皮膚彈性喪失及表面起敏, 促使其過早老化。此項技藝中亦已知波長自挪至 光線(UV-B)會造成紅斑及皮膚曬傷’复 不木〈 膚色發展。 ’、知告自然之棕褐 雖然人類需要暴露於紫外線輻射以產 愈多證據指出過度暴露於陽光,特別3此維生素D,但愈來 成皮膚之各種問題,包括誘發某=者外線輕射’會造 老化。 膚瘴及誘使皮膚加速 研究亦已提供證據指 内之免疫反應,不論 即於與受輻射之皮 除了此等已確立之健康考量之外, 出暴露至紫外線輻射可負面影響生物 是局部於受UV輻射之皮膚内或系統性 膚遠離之部位。 為ί蛋維待暴露於UV轉射 200303724 發明說明續頁 (2) 減輕 丨重及/ 皮膚 之光 少一 ,包 種益 一種 以保 之皮 光老 之光 之步 生乳 可攝 包含 暴露前調理或處理皮膚,以於暴露期間保護之並甚而 紫外線輻射對皮膚之有害反應,預防皮膚之紅斑、水, 或剝離或鱗片化(過度角質化)之進展。 因此,此項技藝中需要一種可改善及/或強化寵物之 之光保護功能之口服施用組合物。 發明内容 據此,本發明之第一方面致力於提供一種用於皮膚 保護之可^攝食組合物,其包含一種光保護有效量之i)至 種益生乳酸菌或其培養上清液,及ii)至少一種酵母菌 含於一種可攝食之載劑内。 本發明進一步係關於使用光保護有效量之i)至少一 生乳酸菌或其培養上清液,及ii)至少一種酵母菌及/或 類胡蘿蔔素或衍生物以製備一種可攝食组合物,其用 護寵物皮膚抵抗太陽輻射,例如:紫外線及所有相關 膚病變,例如:紅斑、發炎、曬傷、皮膚障壁功能、 化、免疫系統改變等。 最後一方面,本發明係關於一種用以改善寵物皮膚 保護功能之方法,其包含對寵物口服投予一種組合物 驟,該組合物中包含一種光保護有效量之i)至少一種益 酸菌或其培養上清液,及ii)至少一種酵母菌,於一種 食之載劑内。 本發明亦提供一種減少寵物之老化作用之方法,其 以上述寵物食品組合物餵食寵物之步驟。 根據本發明之組合物對於皮膚保護及皮膚著色具有特別 200303724 發明說明續頁 (3) 之益處,其可有助於降低太陽輻射相關性壓力對皮膚之作 用。 實施方式 於下列說明中,“NCC”代表納思透菌種中心(Nestld Culture Collection)(納思透研究中心,Vers-chez-les-Blanc,Lausanne,瑞 士)。“光保護”一辭係用以說明嘗試以阻斷或降低皮膚暴露 於太陽輻射下之不良臨床性、組織學性及免疫學性作用。 根據本_發明,主要組合物包含至少一種益生乳酸菌或雙 歧桿菌或其培養上清液,及至少一種酵母菌之合併混合物 作為活性劑。 事實上,目前已驚奇並出乎意料地確定此等非常特別構 成物之混合可引發與皮膚之光保護有關之強化作用或反 應。 益生菌為無病原性及無毒性之生物,其通過胃及小腸仍 能存活。隨著宿主之連續消化作用且最後可定殖於腸内至 可與其他潛在病原性細菌競爭養份及/或胃腸上之附著位 置之實質量並減少其數目並降低或預防感染。截至目前為 止,已發現許多不同之益生菌,報告指出其均經由生產毒 素、代謝副產物、短鏈脂肪酸及類似者來發揮其在腸内之 作用。 現已顯示益生菌確實亦可於個體内遠離其定殖區域之位 置發揮作用。且特定言之,頃已驚奇地發現對皮膚具有協 同光保護作用之組合物可藉由將一種益生性微生物及一種 酵母菌合併至一種可攝食之載劑内而得。 200303724 _ (4) 發明說明續頁 於一較佳具體實施例中,可包入載劑内之益生菌係選自 由乳酸菌所組成之群組,特別是:乳酸桿菌屬、雙歧桿菌 屬或腸球菌屬,且更佳為約氏乳酸桿菌(Lactobacillus johnsonii),囉伊氏乳酸桿菌(Lactobacillus reuteri),雷曼氏乳 酸桿菌(Lactobacillus rhamnosus), 副乾酷乳酸桿菌 (Lactobacillus paracasei),乾酪乳酸桿菌(Lactobacillus casei)或 分歧雙歧桿菌(Bifidobacterium bifidum),短雙歧桿菌 (Bifidobacterium breve),長雙岐桿菌(Bifidobacterium Longum), 動物雙岐桿菌(Bifidobacterium animalis),乳酸雙岐桿菌 (Bifidobacterium lactis),嬰兒雙岐桿菌(Bifidobacterium infantis),青春雙岐桿菌(Bifidobacterium adolescentis),假鍊狀 雙岐桿菌(Bifidobacterium pseudocatenulatum),糞腸球菌 (Enterococcus faecium),腸球菌(Enterococcus sp)或其混合物。 根據一最佳具體實施例,約氏乳酸桿菌NCC 533、副乾酪 乳酸桿菌NCC 2461、青春雙岐桿菌NCC 251及長雙岐桿菌NCC 490係在布達佩斯協定之下,由巴斯德研究所(28 rue du Docteur Roux, F-75024 Paris cddex 15)分別於 30.06.92,12.01.99, 15.04.99及15.03.99寄存且其寄存號碼分別為CNCM 1-1225, CNCM 1-2116,CNCM 1-2168及 CNCM 1-2170。
Hansen (Chr. Hansen A/S? 10-12 Boege Alle, P.O. Box 407, DK-2970 Hoersholm,Danemark)所提供之乳酸雙岐桿菌菌株 (ATCC27536)亦可使用。 根據本發明之益生性微生物可包括呈存活型式、半活化 或去活化型式,例如··凍乾粉末。產品中可包含之微生物 (5) (5)200303724 發明說明續頁 培養上清液亦可視需要呈濃縮型式 · , 取泪土八。其亦可包括於膠囊型 式中。若使用益生菌培養液之上、、杳 , 上,目履,則該上清液可直接 使用或可於包含入產物前先經一哎 4夕個純化步驟以濃縮或 分離活性成份/代謝物。用以純化化合物及測定其於所得區 分内之活性之方法和技術係為熟習此項技藝者所熟知者。 存在於載劑中之益生乳酸菌量可 里」為至少10 Cfu/公克可攝 食之載劑,較佳為自約1〇5至1〇丨5 f cnl/公克可攝食之載劑,且 更佳為自—1〇7至l〇u Cfu/公克可攝食之载劑。 其可呈分散型式混合於適當之載劑,例如:纟、有機溶 劑及脂性物質,包括油類中,無論單獨或以混合物狀。 根據本發明之组合物亦包含酵母菌。於一較佳具體實施 例中,該酵母菌係為選自由子囊菌亞門(ASC⑽ycotina)或不 完全菌亞門(Deuteromycotina)所組成之群組之任意食品級酵 母菌。於一較佳具體實施例中,該酵母菌可選自由德巴利 酵母(Debaryomyces)、克魯維酵母 Kluyveromyces)、沙卡洛酵 母(Saccharomyces)、亞洛伊亞酵母(Yarrowia)、接合酵母 (Zygosaccharomyces)、念珠菌(Candida)及佛杜托魯拉酵母 (Rhodutorula)所組成之群組,且較佳為 Saccharomyces caerevisae (麵包酵母)。 此等酵母菌可呈乾燥或凍乾萃取物之形式。其可以至少 105 cfu/公克可攝食之載劑之量存在於載劑中,且較佳為自 約105至1015 cfu/公克可攝食之載劑,且更佳為自1〇7至1〇12 cfu/ 公克可攝食之載劑,該量係視特定酵母菌之特性及活性而 定0 -10- 200303724 (6) 發明說明續頁 該類胡蘿蔔素可為一種有或無前維生素A活性之類胡 蔔素。其可為β-胡蘿蔔素、γ-胡蘿蔔素、α-胡蘿蔔素、茄 素、玉蜀黍黃素及葉黃素,或其混合物。類胡蘿®素可 自合成或天然來源或包含於天然萃取物内。若類胡蘿蔔 係來自天然來源,其較佳係得自植物原料,其中該植物 活體内或活體外生長。萃取類胡蘿蔔素之方法係為此項 藝中所熟知。該類胡蘿蔔素可以自1〇_12%至20%重量比之 存在於氣劑中且較佳為自0.00001毫克至50毫克/天且更佳 自0.001毫克至30毫克/天。 亦可使用多種乳酸菌、酵母菌及/或類胡蘿蔔素之混 物。 載劑可為任意寵物食品或醫藥產品,或一種營養補給 或一種治療品,其中可内含益生性微生物、酵母菌及/或 胡蘿蔔素。製備載劑之方法係為常識。 該組合物可作為正常膳食之補充品或作為完整營養寵 食品之成份投予寵物。其亦可為一種醫藥組合物。 根據本發明之完整營養寵物食品組合物可呈粉末、乾 形式、治療或濕的、冷的或架售安定之寵物食品產品。 等寵物食品可藉由此項技藝中已知之方法生產。除了植 及植物萃取物之外,此等寵物食品可包括任何一或多種 粉來源、蛋白質來源及脂質來源。 適當之澱粉來源係為例如:穀類及豆類,例如:玉米 稻米、小麥、大麥、燕麥、黃豆及其混合物。適當之蛋 質來源可選自任何適當動物或植物蛋白質源;例如:肉 蘿 紅 來 素 係 技 量 為 合 品 類 物 燥 此 物 澱 Λ 白 及 200303724 發明說明續頁 ⑺ 餐食、豬肉餐、魚肉餐、大豆蛋白濃縮物、牛乳蛋白、麵 筋及類似者。對於較年長之動物,其蛋白質源較佳為含有 一種高品質蛋白質。適當之脂質來到包括肉類、動物脂肪 及植物脂肪。
澱粉、蛋白質及脂質之選擇主要決定於動物之營養需 求、美味考量及產品供應型式。對於年長寵物而言,寵物 食品較佳為含有較年輕寵物之寵物食品較低比例之脂肪。 再者,澱_粉來源可包括稻米、大麥、小麥及玉米之一或多 種0 寵物食品亦可視需要包含一種益生素或其他活性劑,例 如一種長鏈脂肪酸。寵物食品内之益生素量較佳為低於10% 重量比。舉例言之,寵物食品中可含約0.1%至約5%重量比 之益生素。針對使用菊苣作為益生素源之寵物食品而言, 其内含之菊苣可為該飼料混合物之約0.5%至約10%重量 比;較佳為約1%至約5%重量比。
適當之長鏈脂肪酸包括亞麻油酸、α-次亞麻油酸、γ-次亞 麻油酸、二十碳五婦酸及二十二碳六婦酸。魚油係為二十 碳五婦酸及二十二碳六婦酸之適當來源。琉璃苣油、黑醋 栗籽油及月見草油係為適當之γ-次亞麻油酸來源。紅花 油、葵花油、玉米油及大豆油係為適當之亞麻油酸來源。 倘若需要,寵物食品可添加礦物質及維生素使其營養完 整。再者,各種其他成份,例如:糖、鹽、香料、調味料、 調味劑及類似者亦可視需要併入寵物食品内。 乾燥寵物食品之適當製程係為擠壓烹調,雖然焙烤及其 -12- 200303724 他適⑤Μ程亦可使用。若為擠壓烹調,則該乾燥寵物食品 通長呈粗粒狀供應。若使用益生素,該益生素可於加工前 先與乾ι寵物食品之其他成份混合。一種適當之製程係說 明於歐洲專利申請案號0850569中。若使用益生性微生物, 則孩生物較佳為披覆於乾燥寵物食品上或填充於其内。一 種適當《製程係說明於歐洲專利申請案號〇862863中。 針對澄式食品,可使用說明於美國專利第4,781,939及 ^32,137^之製程生產仿造肉製品。亦可使用其他用以生產 厚片型式產品之步驟;例如:於蒸氣烤爐中烹煮。或者, 條狀型式產品之生產可藉由將適當之原料肉乳化以生產肉 礼化物’添加適當之凝膠劑’並於充填至罐頭或其它容器 之如將肉乳化物加熱。 另一方面,本發明係關於一種用以改善寵物皮膚之光保 噗功能之方法,其包含對寵物口服施用一種含光保護有效 里之1)至少一種益生乳酸菌或其培養上清液,及ii)至少一種 酵母菌及/或一種類胡蘿萄素或其衍生物,於一種可攝食之 載劑内之組合物之步驟。 個體消耗之組合物量係視所欲之效果而定。然而,通常 組合物之量若可提供每日约105至Μ2個生物,該生物可為活 的或死的,及0.00001至50毫克之類胡蘿蔔素即已足夠。 組合物係於暴露於紫外線輻射,特別是暴露於陽光之前 或期間施用於個體。倘若可預知暴露時間,則該組合物最 好於10至20天前使用,並於暴露期間延續使用。 為要進一步說明本發明及其優點,故提供下列特定膏 200303724 __ (9) I發明說 例,咸知其係僅供作說明並且絕無限制性。於下列實例中, 如上述說明者,所有百分比均為重量比,除非另有指明。 實施例 實例1 ··乾狗食 一種飼料混合物’其由組成為約5 8 %重量比之玉米、約 5.5%重量比之玉米麵質、約22°/。重量比之雞肉、約2.5。/。乾菊 苣,其餘為鹽類、維生素及礦物質。 將此飼—料混合物送入預調理機内並濕化。再將濕化飼料 送入擠壓烹調機内並使之膠狀化。將留在擠壓機内之膠狀 基質推送使之透過鋼模並擠出。將擠出物切成適合银養狗 類之塊狀,於約110°c下乾燥約20分鐘,再冷卻以形成丸塊。 此時,可加入其中一種下列菌株·· CNCM 1-1225 , CNCM 1-2116,CNCM 1-2168,CNCM 1-2170或 ATCC 27536之;東乾粉末 及麵包酵母之凍乾粉末(使其相對量均為約1.0E+05-1.0E+12 cfu/天)並混合至產品中。再者’相同量之細菌可於丸塊在 50-60°C下乾燥數分鐘後噴灑於冷卻之丸塊上。 此等乾狗食有助於保護寵物之皮膚天然防禦功能以抵抗 太陽之有害UV光。 實例2 :罐裝寵物食品及補充品 一種混合物係製備自73%之豬軀體、豬肺及牛肝(磨碎), 16%之小麥粉’ 2%之色素、維生素及無機鹽類。將此混合 物於12°C下乳化並擠壓成布丁狀,再於90。(:下烹煮。將之 冷卻至30°C並切厚片,將45%之此等厚片與55%之由98%水、 1%色素與1%瓜樹膠製備成之醬汁混合。填充至馬口鐵罐並 200303724 (10) 發明說明續頁 於125°c下滅菌40分鐘。因益生補充品係於供應前與寵物食 品混合,故與下列菌株之一額外包裝(例如:小袋):CNCM 1-1225,CNCM 1-2116,CNCM 1-2168,CNCM 1-2170或 ATCC 27536 及β-胡蘿蔔素及康乾之麵包酵母。其用於寵物之相對量為 約105-1012cfu/天之微生物及0.1至50毫克之類胡蘿蔔素,其可 以附帶於罐頭(例如:於罐頭頂部)之方式供應。
-15-
Claims (1)
- 200303724 拾、申請專利範圍 1· 一種用於皮膚之光保護之可攝食組合物,其包含一種光 保護有效量之i)至少一種益生乳酸菌或其培養上清液, 及ii)至少一種酵母菌及/或類胡蘿蔔素或衍生物,包含於 一種可攝食之載劑内。 2·如申請專利範圍第1項之組合物,其中該乳酸菌係選自由 乳酸菌所組成之群組,特別是乳酸桿菌屬、雙歧桿菌屬 或腸球r菌屬。 3·如申請專利範圍第1或2項之組合物,其中該乳酸菌係為 約氏乳酸桿菌(Lactobacillus johnsonii),囉伊氏乳酸桿菌 (Lactobacillus reuteri),雷曼氏乳酸桿菌(Lactobacillus rhamnosus),副乾酷乳酸桿菌(Lactobacillus paracasei),乾酷 乳酸桿菌(Lactobacillus casei)或分歧雙歧桿菌 (Bifidobacterium bifidum),短雙歧桿菌(Bifidobacterium breve) ,長雙岐桿菌(Bifidobacterium Longum),動物雙岐桿菌 (Bifidobacterium animalis)?乳酸雙岐桿菌(Bifidobacterium lactis),嬰兒雙岐桿菌(Bifidobacterium infantis),青春雙岐 桿菌(Bifidobacterium adolescentis),假鍊狀雙岐桿菌 (Bifidobacterium pseudocatenulatum) » 糞腸球菌(Enterococcus faecium),腸球菌(Enterococcus sp)或其混合物。 4. 如申請專利範圍第1至3項中任一項之組合物,其中該乳 酸菌係為 CNCM 1-1225,CNCM 1-2116,CNCM 1-2168或 CNCM 1-2170 〇 5. 如申請專利範圍第1至4項中任一項之組合物,其中該益 生乳酸菌係内含於載劑中之存活型式、半活化或去活化 200303724 申請專利範圍續頁 型式’較佳為凍乾粉末型式。 該類 ,例 、玉 該酵 酵母 亞酵 朱菌 所組 麵包 現之 養完 上清 備一 關之 係為 ,副 6·如申請專利範圍第1至$項中任一項之組合物,其中 胡蘿蔔素係為有或無前維生素A活性之類胡蘿蔔素 如:β_胡蘿萄素、γ_胡蘿蔔素、心胡蘿蔔素、茄紅素 蜀黍育素及葉黃素或其混合物。 7·如申請專利範圍第1至6項中任一項之組合物,其中 母菌係選自由德巴利酵母(Debaryomyces)、克魯維 (Kluyv*eromyces)、沙卡洛酵母(saccharomyces)亞洛伊 母(Yarrowia)、接合酵母(Zyg0saccharomyces)、念 (Candida)及維杜托魯拉酵母(Rhodutorula)或其混合物 成之群組。 8·如申請專利範圍第7項之組合物,其中該酵母菌係為 酵母。 9. 如申凊專利範圍第1至§項中任一項之組合物,其呈 型式為 i) 一種呈粉末' 乾或濕、冷或架售安定型式之營 整寵物食品或, ii) 呈膳食附屬品或補充品或治療品型式。 10. —種光保護有效量之至少一種益生乳酸菌或其培養 液及至少一種酵母菌及或類胡蘿蔔素之應用,以製 種用以保護皮膚抵抗太陽輻射並減輕或預防所有相 皮膚病變之可攝食之載劑。 11·如申請專利範圍第10項之應用,其中該益生乳酸菌 約氏乳酸桿菌,囉伊氏乳酸桿菌,雷曼氏乳酸桿菌 200303724 申凊專利範圍續頁 乾酪乳酸桿菌,乾酪乳酸桿菌或分歧雙歧桿菌,短雙歧 桿菌,長雙岐桿菌,動物雙岐桿菌,乳酸雙岐桿菌,嬰 兒雙岐桿菌,青春雙岐桿菌,假鍊狀雙岐桿菌,糞腸球 囷,細球菌或其混合物。 12.如申請專利範圍第10或丨丨項之應用,其中該乳酸菌係為 CNCM 1-1225,CNCM 1-2116,CNCM 1-2168 , CNCM 1-2170 戍 ATCC 27536 〇 13·如申請·專利範圍第10至12項中任一項之應用,其中該酵 母菌係選自由德巴利酵母菌(Debaryomyces)、克魯維酵母 (Kluyveromyces)、沙卡洛酵母(Saccharomyces)、亞洛伊亞酵 母菌(Yarrowia)、接合酵母(Zygosaccharomyces)、念珠菌 (Candida)及佛杜托魯拉酵母菌(Rh〇dut〇ruia)或其混合物所 組成之群組。 14.如申請專利範圍第1〇至13項中任一項之應用,其中該益 生乳酸菌係以約1〇5至10i2cfu/公克載劑之量,酵母菌以约 105至1015 cfu/公克載劑之量存在於載劑中。 15·如申請專利範圍第10至13項中任一項之應用,其中該類 胡蘿蔔素係以1(Γ12%至20%重量比之量存在於載劑中。 16.如申請專利範圍第10至15項中任一項之應用,以製備— 種可用以降低寵物之光老化作用之組合物。 17· —種用以改善寵物皮膚之光保護功能之方法,其包含對 寵物口服施用一種組合物之步驟,該組合物包含一種光 保護有效量之i)至少一種益生乳酸菌或其培養上清液, 及Π)至少一種酵母菌及/或類胡蘿蔔素或衍生物,於一種 200303724 申請專利範圍續頁 可攝食之載劑内。 18.如申請專利範圍第17項之方法,其中該組合物係如申請 專利範圍第1至9項。200303724 陸、(一)、本案指定代表圖為:第_圖 (二)、本代表圖之元件代表符號簡單說明: 柒、本案若有化學式時,請揭示最能顯示發明特徵的化學式·
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02075702 | 2002-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200303724A true TW200303724A (en) | 2003-09-16 |
Family
ID=27741185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW092103672A TW200303724A (en) | 2002-02-21 | 2003-02-21 | Pet food composition for skin photoprotection |
Country Status (14)
Country | Link |
---|---|
US (2) | US20050158291A1 (zh) |
EP (1) | EP1478242B1 (zh) |
JP (2) | JP2005517419A (zh) |
CN (1) | CN100592905C (zh) |
AR (1) | AR038593A1 (zh) |
AU (1) | AU2003210311C1 (zh) |
BR (1) | BR0307840A (zh) |
CA (1) | CA2476619C (zh) |
ES (1) | ES2462535T3 (zh) |
MX (1) | MXPA04008187A (zh) |
RU (1) | RU2334404C2 (zh) |
TW (1) | TW200303724A (zh) |
WO (1) | WO2003070019A1 (zh) |
ZA (1) | ZA200407552B (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2297181T3 (es) * | 2002-02-21 | 2008-05-01 | Societe Des Produits Nestle S.A. | Una composicion fotoprotectora para la piel, de administracion oral. |
ES2263990T3 (es) * | 2002-02-21 | 2006-12-16 | Societe Des Produits Nestle S.A. | Composicion oralmente administrable para la fotoproteccion de la piel. |
US20050118234A1 (en) * | 2003-12-01 | 2005-06-02 | The Iams Company | Methods and kits related to administration of a fructooligosaccharide |
US20060228448A1 (en) * | 2005-04-11 | 2006-10-12 | The Iams Company | Pet food compositions comprising two components |
US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US20110027417A1 (en) * | 2009-07-31 | 2011-02-03 | Patrick Joseph Corrigan | Process for Dusting Animal Food |
US9173423B2 (en) * | 2009-07-31 | 2015-11-03 | The Iams Company | Animal food kibble with electrostatically adhered dusting |
US9210945B2 (en) * | 2009-07-31 | 2015-12-15 | The Iams Company | Animal food having low water activity |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
US8691303B2 (en) * | 2009-07-31 | 2014-04-08 | The Iams Company | Dusted animal food |
CN101822326B (zh) * | 2009-11-30 | 2012-06-27 | 上海可可庄进出口有限公司 | 一种用于护理宠物皮肤的食品及其制备方法 |
EP2654452B1 (en) | 2010-12-20 | 2017-01-04 | Hill's Pet Nutrition, Inc. | Pet food compositions for inducing a satiety response |
EP3256004A1 (en) | 2015-02-13 | 2017-12-20 | Mars, Incorporated | Pet food feeding system |
WO2016133909A1 (en) | 2015-02-16 | 2016-08-25 | Mars, Incorporated | Interlocking kibble |
MX2017013715A (es) | 2015-04-28 | 2018-03-02 | Mars Inc | Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado. |
SG11201806603YA (en) * | 2016-03-24 | 2018-09-27 | Meiji Co Ltd | Composition for inhibiting erythema formation, method of using same, method for preparing same, method for inhibiting erythema, and lactic acid bacteria producing substance |
AU2018378419A1 (en) | 2017-12-06 | 2020-07-09 | Lac2biome S.r.l. | Composition based on probiotics and uses thereof |
CN108641991A (zh) * | 2018-07-11 | 2018-10-12 | 江苏恒丰强生物技术有限公司 | 一种复合活菌制剂和其制备方法及其应用 |
CN111909882B (zh) * | 2020-09-10 | 2022-05-13 | 青岛普罗百世生物科技有限公司 | 一种副干酪乳杆菌及其在宠物犬犬粮中的应用 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3920834A (en) * | 1970-07-10 | 1975-11-18 | Hoffmann La Roche | Light-screening compositions and method |
US3946123A (en) * | 1975-03-10 | 1976-03-23 | Star-Kist Foods, Inc. | Canned pet food |
DE3536342A1 (de) * | 1985-10-11 | 1987-10-08 | Walter Dr Wolf | Heilmittel aus milch, milchprodukten und milchsauren obst-, obstpflanzen- und gemuesesaeften |
DE3711054A1 (de) * | 1987-04-02 | 1988-10-13 | Socop Nahrungsmittel | Biophysikalisch derivatisiertes hefepraeparat, verfahren zu dessen herstellung und dieses hefepraeparat enthaltende futtermittel und pflanzenwuchsstoffe |
US4806368A (en) * | 1987-09-16 | 1989-02-21 | Reddy Malireddy S | Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation |
US4963385A (en) * | 1989-06-02 | 1990-10-16 | Nabisco Brands, Inc. | Stabilized emulsions containing highly unsaturated oils |
US5223491A (en) * | 1989-11-09 | 1993-06-29 | Donzis Byron A | Method for revitalizing skin by applying topically water insoluble glucan |
CH680972A5 (zh) * | 1990-09-28 | 1992-12-31 | Nestle Sa | |
DK0768375T4 (da) * | 1992-07-06 | 2002-09-16 | Nestle Sa | Mælkesyrebakterier |
JP3347381B2 (ja) * | 1993-01-27 | 2002-11-20 | 協和醗酵工業株式会社 | ペットフード |
JPH07194317A (ja) * | 1993-12-29 | 1995-08-01 | Nichinichi Seiyaku Kk | ペットフード |
AUPM823094A0 (en) * | 1994-09-16 | 1994-10-13 | Goodman Fielder Limited | Probiotic compositions |
US5527533A (en) * | 1994-10-27 | 1996-06-18 | Board Of Trustees Of The University Of Illinois | Method of retarding and ameliorating central nervous system and eye damage |
US5576015A (en) * | 1995-03-02 | 1996-11-19 | Donzis; Byron A. | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
JPH08298982A (ja) * | 1995-05-02 | 1996-11-19 | Aasu Giken:Kk | 複合微生物製剤 |
JPH0919283A (ja) * | 1995-07-06 | 1997-01-21 | Hisatoki Komaki | 乳酸菌及び酵母の菌体成分複合体の製造方法 |
FR2749758B1 (fr) * | 1996-06-12 | 1998-08-07 | Oenobiol Sa Lab | Composition a activite bronzante et photoprotectrice et ses applications esthetiques |
US6030650A (en) * | 1996-11-22 | 2000-02-29 | Princeton Nutrition, L.L.C. | Complete nutritional milk compositions and products |
FR2756181B1 (fr) * | 1996-11-26 | 1999-03-05 | Au Mont Beaute | Composition cosmetique, pharmaceutique a base de culture inactivee de bacteries bifidobacterium, d'huile de menthe et d'un acide |
US5952033A (en) * | 1996-12-24 | 1999-09-14 | Nestec S.A. | Gelatinized cereal product containing oligosaccharide and processes of preparing and using same |
FR2757769B1 (fr) * | 1996-12-31 | 1999-02-05 | Boiron | Complement nutritionnel absorbable per os destine a proteger la peau contre les effets nocifs des rayons du soleil |
EP0862863B9 (en) * | 1997-01-09 | 2009-08-12 | Societe Des Produits Nestle S.A. | Cereal product containing probiotics |
EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
AU760113C (en) * | 1997-11-18 | 2004-04-22 | Pioneer Hi-Bred International, Inc. | Compositions and methods for genetic modification of plants |
JP4163276B2 (ja) * | 1998-02-05 | 2008-10-08 | 独立行政法人理化学研究所 | 機能性組成物 |
DE19819475A1 (de) * | 1998-04-30 | 1999-11-04 | Basf Ag | Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung |
US6524574B1 (en) * | 1998-05-29 | 2003-02-25 | Agri-King, Inc. | Probiotic mixture intended for monogastric animals to control intestinal flora populations |
US6156355A (en) * | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
DE60039177D1 (de) * | 1999-09-07 | 2008-07-24 | Nestle Sa | Verfahren zur verbesserung der haut und des pelzes von haustieren |
CA2383715C (en) * | 1999-09-09 | 2007-11-13 | Societe Des Produits Nestle S.A. | Improving condition of elderly pets |
MXPA02009342A (es) * | 2000-03-24 | 2003-09-22 | Nestle Sa | Uso de bacterias de acido lactico para el tratamiento de la peritonitis. |
JP2001309753A (ja) * | 2000-04-28 | 2001-11-06 | Natl Fedelation Of Agricult Coop Assoc | 犬特有の感染症の予防・治療用ドッグフード |
RU2178975C1 (ru) * | 2000-06-08 | 2002-02-10 | Борц Михаил Самуилович | Пищевой продукт с биологически активными добавками |
JP2002058434A (ja) * | 2000-08-21 | 2002-02-26 | Nisshin Shiryo Kk | 動物用飼料添加物 |
EP1364586A1 (en) * | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
AU2004227998A1 (en) * | 2003-04-02 | 2004-10-21 | Pharmachem Laboratories, Inc. | Novel probiotic compositions and methods of using the same |
-
2003
- 2003-02-18 JP JP2003568994A patent/JP2005517419A/ja active Pending
- 2003-02-18 RU RU2004127988/13A patent/RU2334404C2/ru not_active IP Right Cessation
- 2003-02-18 WO PCT/EP2003/001687 patent/WO2003070019A1/en active Application Filing
- 2003-02-18 CA CA2476619A patent/CA2476619C/en not_active Expired - Fee Related
- 2003-02-18 BR BR0307840-0A patent/BR0307840A/pt not_active Application Discontinuation
- 2003-02-18 CN CN03804083A patent/CN100592905C/zh not_active Expired - Fee Related
- 2003-02-18 MX MXPA04008187A patent/MXPA04008187A/es active IP Right Grant
- 2003-02-18 EP EP03742552.7A patent/EP1478242B1/en not_active Revoked
- 2003-02-18 US US10/505,285 patent/US20050158291A1/en not_active Abandoned
- 2003-02-18 AU AU2003210311A patent/AU2003210311C1/en not_active Ceased
- 2003-02-18 ES ES03742552.7T patent/ES2462535T3/es not_active Expired - Lifetime
- 2003-02-21 TW TW092103672A patent/TW200303724A/zh unknown
- 2003-02-24 AR ARP030100587A patent/AR038593A1/es not_active Application Discontinuation
-
2004
- 2004-09-20 ZA ZA2004/07552A patent/ZA200407552B/en unknown
-
2008
- 2008-12-18 US US12/338,677 patent/US20090104169A1/en not_active Abandoned
-
2010
- 2010-07-16 JP JP2010161655A patent/JP2010263910A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2003210311A1 (en) | 2003-09-09 |
EP1478242B1 (en) | 2014-04-30 |
BR0307840A (pt) | 2004-12-07 |
EP1478242A1 (en) | 2004-11-24 |
ES2462535T3 (es) | 2014-05-23 |
MXPA04008187A (es) | 2004-11-26 |
CN1633243A (zh) | 2005-06-29 |
ZA200407552B (en) | 2005-12-28 |
JP2010263910A (ja) | 2010-11-25 |
CN100592905C (zh) | 2010-03-03 |
RU2334404C2 (ru) | 2008-09-27 |
US20050158291A1 (en) | 2005-07-21 |
JP2005517419A (ja) | 2005-06-16 |
AU2003210311B2 (en) | 2008-02-14 |
AU2003210311C1 (en) | 2009-04-02 |
WO2003070019A1 (en) | 2003-08-28 |
CA2476619A1 (en) | 2003-08-28 |
RU2004127988A (ru) | 2005-05-10 |
AR038593A1 (es) | 2005-01-19 |
CA2476619C (en) | 2011-09-20 |
US20090104169A1 (en) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090104169A1 (en) | Pet food composition for skin photoprotection | |
AU2007216461B2 (en) | Use of bifidobacterium longum for the prevention and treatment of inflammation | |
Bomba et al. | Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids | |
JP4308337B2 (ja) | 即席食用乾燥シリアル製品 | |
RU2580881C2 (ru) | Корма для домашних животных, содержащие пробиотические микроорганизмы | |
TWI344845B (en) | Orally administrable composition for the photoprotection of the skin | |
ES2307531T3 (es) | Metodo para mejorar la piel y el pelaje de los animales de compañia. | |
RU2350124C2 (ru) | Питательная композиция для улучшения состояния кожи и предотвращения кожных заболеваний | |
CN102724987A (zh) | 非复制性微生物及其免疫强化效应 | |
NO330469B1 (no) | Naeringssammensetning og anvendelse av denne. | |
CN104822363B (zh) | 至少一种多不饱和脂肪酸和至少一种类胡萝卜素的组合用于改善指甲品质的用途 | |
Sena | NUTRACEUTICALS IN LIVESTOCK FEEDS |